Mereo BioPharma Group plc MREO

$ 3.3 0.3%

Annual report 2022
added 12-21-2024

Mereo BioPharma Group plc Balance Sheet 2011-2024 | MREO

Annual Balance Sheet Mereo BioPharma Group plc

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-	-6.69 M	-8.39 M	-10.4 M	-31.2 M	-50.5 M	-76.9 M	-	-	-	-
Long Term Debt	-	-	16.1 M	5.37 M	14.6 M	18.8 M	3.13 M	2.8 M	-	-	-	-
Long Term Debt Current	466 K	622 K	636 K	2.59 M	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	69.4 M	16.3 M	18.3 M	24.2 M	4.3 M	2.94 M	-	-	-	-
Total Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	26.2 M	38.4 M	77.9 M	46.2 M	34.5 M	33.9 M	7.51 M	5.76 M	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-	-310 M	-146 M	-111 M	-79.3 M	-33.6 M	-12.2 M	-	-	-	-
Total Assets	88.1 M	126 M	62.9 M	86.4 M	67.3 M	96.3 M	86.8 M	107 M	-	-	-	-
Cash and Cash Equivalents	56.3 M	94.3 M	23.5 M	16.3 M	25 M	50 M	53.6 M	-	-	-	-	-
Book Value	61.9 M	88 M	-15 M	40.3 M	32.8 M	62.5 M	79.3 M	102 M	-	-	-	-
Total Shareholders Equity	-	-	-15 M	40.3 M	32.8 M	62.5 M	79.3 M	-	-	-	-	-

All numbers in GBP currency

Quarterly Balance Sheet Mereo BioPharma Group plc

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	-	-	1.75 M	-	1.95 M	-	1.16 M	-	11.2 M	-	9.32 M	-	13.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	25.9 M	-	54.4 M	-	69.4 M	-	63.2 M	-	16.3 M	-	27 M	-	18.3 M	-	-	-	24.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	-	38.4 M	-	64.2 M	-	77.9 M	-	85.5 M	-	46.2 M	-	48.1 M	-	34.5 M	-	-	-	33.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-	-	-	-297 M	-	-298 M	-	-310 M	-	-271 M	-	-146 M	-	-127 M	-	-111 M	-	-	-	-79.3 M	-	-	-	-40.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	-	-	-	-	126 M	-	145 M	-	62.9 M	-	110 M	-	86.4 M	-	107 M	-	67.3 M	-	-	-	96.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	-	-	-	-	94.3 M	-	110 M	-	23.5 M	-	56.8 M	-	16.3 M	-	28.3 M	-	25 M	-	-	-	50 M	-	-	-	53.6 M	-	-	-	12.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-	-	-	-	88 M	-	80.7 M	-	-15 M	-	24.2 M	-	40.3 M	-	59 M	-	32.8 M	-	-	-	62.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-	-	-	-	88 M	-	80.7 M	-	-15 M	-	24.2 M	-	40.3 M	-	59 M	-	32.8 M	-	-	-	62.5 M	-	-	-	79.3 M	-	-	-	62.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in GBP currency